Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Reappraisal of variants previously linked with sudden infant death syndrome: results from three population-based cohorts

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Haploinsufficiency of ARHGAP42 is associated with hypertension

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The Global State of the Genetic Counseling Profession

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Educational delay and attainment in persons with neurofibromatosis 1 in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Novel HARS2 missense variants identified in individuals with sensorineural hearing impairment and Perrault syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Functional Assessment of Variants Associated with Wolfram Syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association of SLC26A4 mutations, morphology, and hearing in pendred syndrome and NSEVA

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  • Franziska Severin
  • Pascal Borry
  • Martina C Cornel
  • Norman Daniels
  • Florence Fellmann
  • Shirley Victoria Hodgson
  • Heidi C Howard
  • Jürgen John
  • Helena Kääriäinen
  • Hülya Kayserili
  • Alastair Kent
  • Florian Koerber
  • Ulf Kristoffersson
  • Mark Kroese
  • Celine Lewis
  • Georg Marckmann
  • Søren Peter Meyer
  • Arne Pfeufer
  • Jörg Schmidtke
  • Heather Skirton
  • Lisbeth Tranebjærg
  • Wolf H Rogowski
Vis graf over relationer

Given the cost constraints of the European health-care systems, criteria are needed to decide which genetic services to fund from the public budgets, if not all can be covered. To ensure that high-priority services are available equitably within and across the European countries, a shared set of prioritization criteria would be desirable. A decision process following the accountability for reasonableness framework was undertaken, including a multidisciplinary EuroGentest/PPPC-ESHG workshop to develop shared prioritization criteria. Resources are currently too limited to fund all the beneficial genetic testing services available in the next decade. Ethically and economically reflected prioritization criteria are needed. Prioritization should be based on considerations of medical benefit, health need and costs. Medical benefit includes evidence of benefit in terms of clinical benefit, benefit of information for important life decisions, benefit for other people apart from the person tested and the patient-specific likelihood of being affected by the condition tested for. It may be subject to a finite time window. Health need includes the severity of the condition tested for and its progression at the time of testing. Further discussion and better evidence is needed before clearly defined recommendations can be made or a prioritization algorithm proposed. To our knowledge, this is the first time a clinical society has initiated a decision process about health-care prioritization on a European level, following the principles of accountability for reasonableness. We provide points to consider to stimulate this debate across the EU and to serve as a reference for improving patient management.European Journal of Human Genetics advance online publication, 24 September 2014; doi:10.1038/ejhg.2014.190.

TidsskriftEuropean journal of human genetics : EJHG
Udgave nummer6
Sider (fra-til)729-35
StatusUdgivet - 2015

ID: 44955804